The sequence of events initiated by interferon and leading to the antiviral state were studied as possible sites for the cell-to-cell transfer of interferon induced viral resistance. The possible role of interferon produced by recipient cells was negated by the demonstration of transfer of resistance in the presence of anti-human interferon antibody and under conditions of a single cycle of VSV growth. Transfer of sensitivity of WISH cells to mouse interferon, possibly through transfer of a membrane receptor, seems unlikely since resistance was transferred in the absence of mouse interferon. From kinetic data and the fact that actinomycin D blocked resistance in human cells for 3 h longer than in mouse cells, it seems unlikely that the mouse antiviral protein itself or its mRNA alone is a likely candidate for the transfer of resistance. Thus, by a process of elimination, we suggest that secondary messenger molecules which transmit the interferon signal from the membrane to the nucleus are the effector substance(s) for the transfer process.
AnkelH.,
ChanyC.,
GalliotB.,
ChevalierM. J.,
RobertM.1973; Antiviral effect of interferon covalently bound to Sepharose. Proceedings of the National Academy of Sciences of the United States of America 70:2360–2363
BaronS.,
BucklerC. E.,
LevyH. B.,
FriedmanR. M.1967; Some factors affecting the interferon-induced antiviral state. Proceedings of the Society for Experimental Biology and Medicine 125:1320–1326
CampbellJ. B.,
GrunbergerF.,
KochmanM. A.,
WhiteS. L.1975; A microplaque reduction assay for human and mouse interferon. Canadian Journal of Microbiology 21:1247–1253
ChanyC.,
AnkelH.,
GalliotB.,
ChevalierM. J.,
GregoireA.1974; Mode of action and biological properties of insoluble interferon. Proceedings of the Society for Experimental Biology and Medicine 147:293–299
CuatrecasasP.1975; Hormone-receptor interactions and the plasma membrane. In Cell Membranes: Biochemistry, Cell Biology and Pathology pp 177–184 Edited by
WeissmanG.,
ClaiborneR.
New York: HP Publishing Co. Ltd;
DesmyterJ.,
MelnickJ. L.,
RawlsW. E.1969; Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells (Vero). Journal of Virology 2:955–961
DianzaniF.,
LevyH. B.,
BergS.,
BaronS.1976; Kinetics of the rapid action of interferon. Proceedings of the Society For Experimental Biology and Medicine 152:593–597
DianzaniF.,
BucklerC. E.,
BaronS.1969; Effect of cycloheximide on the antiviral action of interferon. Proceedings of the Society for Experimental Biology and Medicine 130:519–523
FriedmanR. M.,
PastanI.1969; Interferon and cyclie-3′5′ adenosine monophosphate: potentiation of antiviral activity. Biochemical and Biophysical Research Communications 36:735–740
HughesT. K.,
BlalockJ. E.,
BaronS.1978; Various heterologous cells exhibit interferon induced transfer of viral resistance. Archives of Virology 58:77–80
KohnL. D.,
FriedmanR. M.,
HolmesJ. M.,
LeeG.1976; Use of thyrotropin and cholera toxin to probe the mechanism by which interferon initiates its antiviral activity. Proceedings of the National Academy of Sciences of the United States of America 73:3695–3699
LefkowitzE.,
BaronS.1974; Mechanism of late therapy of viral infections with interferon. International Research Communication System (Research on: Immunology and Allergy; Microbiology, Parasitology and Infectious Diseases) 2:1518
LockartR. Z.Jun1964; The necessity of cellular RNA and protein synthesis for viral inhibition resulting from interferon. Biochemical and Biophysical Research Communications 15:513–518
PithaP. M.,
VengrisV. E.,
ReynoldsF. H.Jun1976; The role of cell membrane in the antiviral effect of interferon. Journal of Supramolecular Structure 4:467–473
PittsJ. D.,
SimmsJ. W.1977; Permeability of junctions between animal cells: intercellular transfer of nucleotides but not of macromolecules. Experimental Cell Research 104:153–163
TaylorJ.1965; Studies on the mechanism of action of interferon. I. Interferon action and RNA synthesis in chick embryo fibroblasts infected with Semliki Forest virus. Virology 25:340–349
WagnerE. R.,
LevyA. H.,
SnyderR. M.,
RatcliffG. A.Jun,
HyattD. R.1963; Biologic properties of two plaque variants of vesicular stomatitis virus (Indiana serotype). Journal of Immunology 91:112–122